Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the.

Slides:



Advertisements
Similar presentations
Fig. 1. IL-21 induces proliferation in CB-derived CD56+ populations. CB/CD34+ (A), and CB/CD56+ (B) cells were cultured.
Advertisements

Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes by Diana Y. Chen, Arumugam Balamurugan,
Dasatinib suppresses in vitro natural killer cell cytotoxicity
Melanoma donor (MD) NK cells are functionally impaired/exhausted.
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad by Anna Frenzel, Verena Labi, Waldemar Chmelewskij, Christian Ploner, Stephan.
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases.
by Rafijul Bari, Teresa Bell, Wai-Hang Leung, Queenie P
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection by Shokrollah Elahi, Toshiro Niki, Mitsuomi Hirashima,
Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs
Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy by Claudia Rossig,
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
by Norman Nausch, Ioanna E
Rapid, Flow Cytometric Assay for NK Alloreactivity Reveals Exceptions to Rules Governing Alloreactivity  Dianne De Santis, Bree A. Foley, Elisabeth John,
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies by Inés González-García,
(A) NK cell cytotoxicity assays against K562, H9, and Raji target cell lines in the presence (black) and absence (white) of an anti-NKp30 antibody, clone.
by Éric Aubin, Réal Lemieux, and Renée Bazin
by Takahiro Kamiya, Desmond Wong, Yi Tian Png, and Dario Campana
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
Volume 25, Issue 3, Pages (March 2017)
Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.
A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and a panel of human and rhesus macaque tissues. A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and.
Gr-1+ MDSC in tumor-bearing mice produce IL-6.
Volume 19, Issue 9, Pages (September 2017)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
The absence of ADCC by nivolumab in vitro.
Volume 26, Issue 4, Pages (April 2018)
Volume 24, Issue 9, Pages (September 2016)
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor.
Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses  Julia A. Wagner, Melissa.
Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in xenografted mice. Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in.
Allergen-specific CD8+ T cells in peanut-allergic individuals
Effect of CD4+ Th1 cytokines and HER2-targeted antibodies on MHC class I restoration and HER2369–377-CD8+ T-cell targeting of HER2-expressing cancer cells.
Anifrolumab does not elicit antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) activity. Anifrolumab does.
Ectopic expression of caveolin-1 in ZR75 human breast cancer cells downregulated survivin and decreased cell proliferation. Ectopic expression of caveolin-1.
Exosome-mediated inhibition of T cells is reversible.
Dox titration and kinetic analyses of CD19CAR expression upon Dox administration and discontinuation. Dox titration and kinetic analyses of CD19CAR expression.
M-MDSC:mast cell cross-talk in the regulation of TNFα production.
Adaptive NK cells resist immunosuppression in the tumor microenvironment. Adaptive NK cells resist immunosuppression in the tumor microenvironment. FACS-sorted.
KIR-CARs/Dap12 trigger robust antigen-specific cytotoxicity in vitro.
Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.
Intracellular TNF-α and IL-4 expression in gated CD33+ monocytes by three-color flow cytometry. Intracellular TNF-α and IL-4 expression in gated CD33+
Flow cytometric analysis of T cell activation.
Cytotoxicity of p5399–107-induced CTL cells.
IL-13Rα2 promotes cell survival and proliferation.
Ectopic expression of CA RSK1 mutant protects melanoma cells from PD98059-mediated apoptosis. Ectopic expression of CA RSK1 mutant protects melanoma cells.
Flow cytometry analysis of intracellular cytokine expression in control PBMC (left set of panels) and following either PMA-ionomycin activation (middle.
ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.
Uptake of TEX by DCs in vivo.
Canonical but not adaptive NK-cell function is suppressed by Tregs.
Inactivation of human TRAC and CD52 genes by TALENs
CD19-CAR-T cells with short and long spacers show specific in vitro function. CD19-CAR-T cells with short and long spacers show specific in vitro function.
PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate distinct mechanisms of regulation. PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate.
Trametinib and combination promote moDC maturation and decrease moDC viability. Trametinib and combination promote moDC maturation and decrease moDC viability.
Role of NO and IFNγ in mast cell–dependent MDSC-suppressive activities
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
Dgk inhibitors enhance the cytotoxic capacity of impaired human mesoCAR-transduced T cells. Dgk inhibitors enhance the cytotoxic capacity of impaired human.
LSECtin, expressed by B16 cells, inhibits the tumor-specific immune responses both in vivo and in vitro. LSECtin, expressed by B16 cells, inhibits the.
Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. A,
LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. Preexpanded.
KIR2DL4 on human mast cells upregulates the invasive activity of HLA-G+ cancer cell lines. KIR2DL4 on human mast cells upregulates the invasive activity.
Effect of BCAA on the progression of cell cycle, expression of p21CIP1, and induction of apoptosis in HepG2 cells in the presence and absence of visfatin.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
EC-derived SP cells are targeted by CD30.CAR T cells.
Varying the MHC-I affinity, TCR affinity or antigen dose alters the phenotype of CD8 T cells ex vivo. Varying the MHC-I affinity, TCR affinity or antigen.
RIL21 and checkpoint blockade restore IFNγ production in Tim-3+PD-1+ intratumoral NK cells from cancer patients. rIL21 and checkpoint blockade restore.
TRP1 transnuclear CD8 T cells are tumoricidal in vitro.
Expression of CAR, endogenous TCR, and target-cell receptors.
Presentation transcript:

Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the absence (mock, gray) or in the presence of anti-CD20 CAR mRNA (CAR, black). Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the absence (mock, gray) or in the presence of anti-CD20 CAR mRNA (CAR, black). A, MOCK and CAR exPBNK were incubated for 4 hours with the BATDA-labeled CD20+ NK-sensitive Ramos (top left), CD20+ NK-resistant Daudi (top middle), and U-698-M (top right) cells at the indicated E:T ratios. In vitro cytotoxicity was measured by standard europium release assay. At indicated by E:T ratios, cytotoxicity of exPBNK expressing anti-CD20 chimeric receptors was significantly higher than that of mock exPBNK. B, MOCK and CAR exPBNK were incubated for 4 hours with the BATDA-labeled CD20− NK-sensitive Jurkat (bottom left) and CD20− NK-resistant Rs4;11 (bottom right) cells at the indicated E:T ratios. In vitro cytotoxicity was measured by standard europium release assay. C, anti-CD20 CAR expressing NK cells inhibit Ramos-cell recovery. MOCK or CAR exPBNK were incubated overnight with Ramos cells at E:T = 3:1. Ramos cells incubated with medium only were used as controls. The total living cells were gated by 7-AAD negative. The living Ramos cells were gated by CD19+ 7-AAD− by flow cytometry analysis. Each data point represents the mean (± SEM; n = 3) percentage of living CD19+ cells versus total living cells. P values using the unpaired Student t test are noted in A, B, and C, respectively. D, MOCK and CAR exPBNK were incubated for 2 hours with the BATDA-labeled CD20+ rituximab-sensitive Raji and rituximab-resistant Raji-2R and Raji-4RH cells at the E:T ratio = 10:1. In vitro cytotoxicity was measured by standard europium release assay. As indicated by E:T ratios, cytotoxicity of exPBNK expressing anti-CD20 chimeric receptors was significantly higher than that of exPBNK without anti-CD20 CAR (P < 0.001) against Raji, Raji-2R, and Raji-4RH cells. Each data point represents the mean (± SEM; n = 4) percentage of specific europium release after culture. P values using the unpaired Student t test are noted. E, expression of HLA class I antigens in Raji, Raji-2R, and Raji-4RH cells was determined by flow cytometry with allophycocyanin-conjugated anti-human HLA-ABC antibody (BD Biosciences). Representative staining results are shown. Yaya Chu et al. Cancer Immunol Res 2015;3:333-344 ©2015 by American Association for Cancer Research